ANNEXON, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ANNEXON, INC. (ANNX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $122.49 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-03-06
- ANNEXON, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-09-30 was $122.62M.
- ANNEXON, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $122.49M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2022-12-31 | $122.49M 10-K · filed 2023-03-06 | |
| 2022-09-30 | $122.62M 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |